FrancophonIA/ELRC3.0 huggingface dataset:
English: No interactions with antibiotic eye drops used in conjunction with surgery have been reported.
Croatian: Nisu prijavljene interakcije s antibiotskim kapima za oči, korištenim u kombinaciji s kirurškim zahvatom.
English: Do not use more than one drop in the affected eye(s) 2 times daily.
Croatian: Nemojte koristiti više od jedne kapi u upaljeno oko (oči) 2 puta dnevno.
English: Water for injections Sodium hydroxide (for pH adjustment)
Croatian: Natrijev hidroksid (za podešavanje pH)
English: One drop contains approximately 33 micrograms bromfenac.
Croatian: Jedna kap sadrži približno 33 mikrograma bromfenaka.
English: What Yellox looks like and contents of the pack
Croatian: Kako Yellox izgleda i sadržaj pakiranja
English: Date of first authorisation: 18.05.2011 Date of latest renewal: 11.01.2016
Croatian: Datum posljednje obnove: 11.01.2016.
English: - Close the bottle cap firmly immediately after use.
Croatian: - Čvrsto zatvorite bočicu odmah nakon upotrebe.
English: If you experience decreased or blurred vision the week after the end of treatment, contact your doctor immediately.
Croatian: U slučaju lošijeg ili zamagljenog vida tjedan dana nakon završetka liječenja, odmah se obratite svom liječniku.
English: Yellox has minor influence on the ability to drive and use machines.
Croatian: Yellox ima mali utjecaj na sposobnost upravljanja vozilima i rada sa strojevima.
English: All topical NSAIDs may slow or delay healing like topical corticosteroids.
Croatian: Svi topikalni NSAIL mogu usporiti ili odgoditi cijeljenje poput topikalnih kortikosteroida.
English: There are no adequate data from the use of bromfenac in pregnant women.
Croatian: Nema odgovarajućih podataka o primjeni bromfenaka u trudnica.
English: - Gently squeeze the bottle to release one drop of Yellox.
Croatian: - Nježno stisnite bočicu za ispuštanje jedne kapi Yelloxa.
English: Therefore, patients should be advised not to wear contact lenses during treatment with Yellox.
Croatian: Stoga bolesnike treba savjetovati da ne nose kontaktne leće tijekom liječenja Yelloxom.
English: Czech Republic czech.info@valeant.com
Croatian: Češka czech.info@valeant.com
English: Ingestion of the 5 ml bottle content corresponds to an oral dose of less than 5 mg bromfenac, which is 30 times lower than daily dose of bromfenac oral formulation formerly used.
Croatian: Ingestija sadržaja bočice od 5 ml odgovara oralnoj dozi od manje od 5 mg bromfenaka, što je 30 puta manje od dnevne doze oralnog oblika bromfenaka koji se nekad koristio.
English: Corneal adverse reactions were only observed in the Japanese population.
Croatian: Nuspojave rožnice primjećene su samo u japanskoj populaciji.
English: Bromfenac shows high binding to plasma proteins.
Croatian: Bromfenak se u velikoj mjeri veže na proteine plazme.
English: The dose is one drop of Yellox in the affected eye(s) twice daily, beginning the next day after cataract surgery and continuing through the first 2 weeks of the postoperative period.
Croatian: Doza je jedna kap Yelloxa u upaljeno oko (oči) dva puta dnevno, počevši sljedeći dan nakon operacije katarakte i nastavljajući tijekom prva 2 tjedna postoperativnog razdoblja.
English: Pregnancy , breastfeeding and fertility
Croatian: Trudnoća, dojenje i plodnost
English: In orally treated humans unchanged parent compound is the major component in plasma.
Croatian: U peroralno liječenih bolesnika, nepromijenjeni ishodišni spoj glavna je komponenta u plazmi.
English: What Yellox is and what it is used for What you need to know before you use Yellox How to use Yellox
Croatian: Što je Yellox i za što se koristi Što morate znati prije nego počnete primjenjivati Yellox Kako primjenjivati Yellox
English: However, 0.9 mg/kg/day in rats at oral doses (900 times the recommended ophthalmic dose) caused embryofoetal lethality, increased neonatal mortality, and reduced postnatal growth.
Croatian: Međutim, oralne doze od 0,9 mg/kg/dan u štakora (900 puta više od preporučene oftalmološke doze) uzrokovale su embrio-fetalnu letalnost, povećanu neonatalnu smrtnost i smanjeni postnatalni rast.
English: Two Phase II multicentre, randomised, double-masked, parallel group studies were conducted in Japan, and two Phase III multicentre, randomised (2:1), double-masked, parallel group, placebocontrolled studies were conducted in the US to assess the clinical safety and efficacy of Yellox dosed twice daily in the treatment of post-operative inflammation in patients undergoing cataract surgery.
Croatian: Dva multicentrična, randomizirana, dvostruko slijepa, ispitivanja paralelnih skupina, faze II, provedena su u Japanu, a dva multicentrična, randomizirana (2:1), dvostruko slijepa, placebom kontrolirana ispitivanja paralelnih skupina, faze III, provedena su u SAD-u kako bi se ocijenila klinička sigurnost i djelotvornost Yelloxa doziranog dva puta dnevno u liječenju postoperativne upale u bolesnika podvrgnutih operaciji katarakte.
English: INSTRUCTIONS ON USE
Croatian: UPUTE ZA UPORABU
English: Several conjugated and unconjugated metabolites have been identified with the cyclic amide being the major urinary metabolite.
Croatian: Identificirano je nekoliko konjugiranih i nekonjugiranih metabolita, a ciklički amid je glavni metabolit u urinu.
English: Continue the drops through the first 2 weeks after your surgery.
Croatian: Nastavite s primjenom kapi tijekom prva 2 tjedna nakon kirurškog zahvata.
English: No abnormal findings or adverse reactions of clinical concern were noted upon administration of two drops 2mg/ml solution four times a day for the period of up to 28 days.
Croatian: Nisu zabilježeni abnormalni nalazi niti nuspojave za kliničku zabrinutost nakon primjene dvije kapi otopine od 2mg/ml četiri puta dnevno u razdoblju do 28 dana.
English: Bromfenac efficiently permeates the cornea of cataract patients: A single dose resulted in a mean peak aqueous humour concentrations of 79±68 ng/ml at 150-180 minutes after dosing.
Croatian: Bromfenak učinkovito prodire u rožnicu bolesnika s kataraktom: jedna doza rezultirala je srednjom vršnom koncentracijom u očnoj vodici od 79±68 ng/ml unutar 150-180 minuta nakon doziranja.
English: Concentrations were maintained for 12 hours in aqueous humour with measurable levels up to 24 hours in major ocular tissues including the retina.
Croatian: Koncentracije su bile održane 12 sati u očnoj vodici s mjerljivim razinama do 24 sata u glavnini očnih tkiva, uključujući mrežnicu.
English: *Serious reports from post-marketing experience of more than 20 million patients ** Observed with four times daily dose
Croatian: *Ozbiljne prijave iz postmarketinškog iskustva na više od 20 milijuna bolesnika
English: 1.What Yellox is and what it is used for
Croatian: Što je Yellox i za što se koristi
English: Susceptible persons
Croatian: Osjetljive osobe
English: Therefore, do not wear contact lenses whilst using Yellox.
Croatian: Iz tog razloga nemojte nositi kontaktne leće dok koristite Yellox.
English: No effects on the breastfed newborn/infant are anticipated since the systemic exposure of the breastfeeding woman to bromfenac is negligible.
Croatian: Ne očekuje se učinak na novorođenčad/dojenčad, budući da je sustavna izloženost dojilja bromfenaku zanemariva.
English: If you notice any of the following side effects while using the drops, contact your doctor immediately:
Croatian: Ako primijetite bilo koju od sljedećih nuspojava prilikom uzimanja kapi, odmah se obratite svom liječniku:
English: Boric acid
Croatian: Boratna kiselina
English: Yellox contains bromfenac and belongs to a group of medicines called non-steroidal antiinflammatory drugs (NSAIDs).
Croatian: Yellox sadrži bromfenak i pripada skupini lijekova koji se nazivaju nesteroidnim protuupalnim lijekovima (NSAIL).
English: Do not use Yellox while wearing contact lenses, since benzalkonium chloride is known to discolour them.
Croatian: Nemojte koristiti Yellox za vrijeme nošenja kontaktnih leća, jer je poznato da benzalkonijev klorid uzrokuje njihovo blijeđenje boje.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Yellox in all subsets of the paediatric population in postoperative ocular inflammation (see section 4.2 for information on paediatric use)
Croatian: Europska agencija za lijekove izuzela je obvezu podnošenja rezultata ispitivanja lijeka Yellox u svim podskupinama pedijatrijske populacije u postoperativnim upalama oka (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: Following twice daily dosing with bromfenac eye drops plasma concentrations were not quantifiable.
Croatian: Nakon doziranja bromfenak kapi za oko dva puta dnevno, koncentracije u plazmi nisu bile mjerljive.
English: Pregnant rabbits treated orally with 7.5 mg/kg/day (7500 times the recommended ophthalmic dose) caused increased postimplantation loss (see section 4.6).
Croatian: Gravidni kunići, liječeni oralno sa 7,5 mg/kg/dan (7500 puta više od preporučene oftalmološke doze) pokazali su povećani postimplantacijski gubitak fetusa (vidjeti dio 4.6).
English: Adverse reactions rarely led to withdrawal, with a total of 8 (0.8%) patients who prematurely discontinued treatment in a study due to an adverse reaction.
Croatian: Nuspojave su rijetko uzrokovale prekid primjene, kod ukupno 8 (0,8%) bolesnika koji su prerano prekinuli liječenje u ispitivanju zbog nuspojava.
English: Since Yellox contains benzalkonium chloride, close monitoring is required with frequent or prolonged use.
Croatian: Budući da Yellox sadrži benzalkonijev klorid, pažljivo praćenje nužno je kod česte ili dugotrajne primjene.
English: Examples of NSAIDs are: acetylsalicylic acid, ibuprofen, ketoprofen, diclofenac.
Croatian: Primjeri NSAIL su: acetilsalicilatna kiselina, ibuprofen, ketoprofen, diklofenak.
English: Hypersensitivity to bromfenac or to any of the excipients listed in section 6.1, or to other nonsteroidal anti-inflammatory medicinal products (NSAIDs).
Croatian: Preosjetljivost na bromfenak ili neku od pomoćnih tvari navedenih u dijelu 6.1, ili na druge nesteroidne protuupalne lijekove (NSAIL).
English: Pharmacotherapeutic group: Ophtalmologicals, Antiinflammatory agents, non-steroids, ATC code: S01BC11.
Croatian: Farmakoterapijska skupina: Oftalmici, protuupalni lijekovi, nesteroidi, ATK oznaka: S01BC11.
English: In vitro studies indicate that bromfenac is mainly metabolised by CYP2C9, which is absent in both iris-ciliary body and retina/choroid and the level of this enzyme in the cornea is less than 1% compared to the corresponding hepatic level.
Croatian: In vitro ispitivanja pokazuju da se bromfenak uglavnom metabolizira putem CYP2C9, koji je odsutan i u irisu-cilijarnom tijelu i u mrežnici/žilnici, a razina ovog enzima u rožnici manja je od 1% u odnosu na odgovarajuću razinu jetrenih enzima.
English: It is unknown whether bromfenac or its metabolites are excreted in human milk.
Croatian: Nije poznato izlučuju li se bromfenak ili njegovi metaboliti u majčino mlijeko.
English: A significantly greater proportion of patients in the Yellox group 64.0% vs. 43.3% in the placebo group (p<0.0001) experienced complete clearance of ocular inflammation at study day 15.
Croatian: Znatno veći udio bolesnika u skupini Yelloxa 64,0% u odnosu na 43,3% u placebo grupi (p <0,0001) imao je potpunu sanaciju očne upale u 15-om danu ispitivanja.
English: After ocular administration the half-life of bromfenac in aqueous humour is 1.4 h indicating rapid elimination.
Croatian: Nakon okularne primjene, poluvijek bromfenaka u očnoj vodici je 1,4h, što ukazuje na brzu eliminaciju.
English: Do not stop using Yellox without speaking to your doctor.
Croatian: Ako prestanete primjenjivati Yellox Nemojte prestati uzimati Yellox bez savjetovanja sa svojim liječnikom.
English: Do not use this medicine after the expiry date which is stated on the bottle and outer carton after “EXP”.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na bočici i kutiji iza oznake „EXP“, odnosno „Rok valjanosti“.
English: After oral administration of 14C-bromfenac to healthy volunteers, urinary excretion was found to be the major route of radioactive excretions, accounting for approximately 82% while faecal excretion represented approximately 13% of the dose.
Croatian: Nakon peroralne primjene 14C-bromfenaka u zdravih dobrovoljaca, utvrđeno je da je urinarna ekskrecija glavni put izlučivanja radioaktivnih metabolita, čineći oko 82%, dok izlučivanje stolicom iznosi oko 13% doze.
English: In vitro, bromfenac inhibited the synthesis of prostaglandins in the rabbit iris ciliary body.
Croatian: In vitro, bromfenak inhibira sintezu prostaglandina u cilijarnom tijelu irisa kunića.
English: UNIQUE IDENTIFIER - 2D BARCODE
Croatian: Yellox 17. JEDINSTVENI IDENTIFIKATOR - 2D BARKOD
English: Detailed information on this medicine is available on the website of the European Medicines Agency http://www.ema.europa.eu
Croatian: Detaljnije informacije o ovom lijeku dostupne su na internetskoj stranici Europske agencije za lijekove http://www.ema.europa.eu.
English: Yellox may be prescribed to breast-feeding woman and have no important influence on fertility.
Croatian: Yellox se može propisati dojiljama i nema značajnog učinka na plodnost.
English: Yellox is a clear yellow liquid (solution) supplied in a pack containing one 5 ml plastic bottle with a screw cap.
Croatian: Yellox je bistra žuta tekućina (otopina) dostupna u pakiranju od jedne plastične bočice od 5 ml sa zatvaračem s navojem.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR SINGLE BOTTLE 5 ML
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA JEDNE BOČICE OD 5 ML
English: There is the potential for cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, and other NSAIDs.
Croatian: Postoji mogućnost ukrižene osjetljivosti na acetilsalicilatnu kiselinu, derivate fenilacetatne kiseline i druge NSAIL.
English: There have been reports that ophthalmic NSAIDs may cause increased bleeding of ocular tissues (including hyphaema) in conjunction with ocular surgery.
Croatian: Izvješća pokazuju da oftalmološki NSAIL mogu prouzročiti povećano krvarenje očnog tkiva (uključujući hifemu) u kombinaciji s očnom kirurgijom.
English: Use of contact lenses
Croatian: Uporaba kontaktnih leća
English: Yellox should be used with caution in patients with known bleeding tendencies or who are receiving other medicinal products which may prolong bleeding time.
Croatian: Yellox treba primjenjivati s oprezom u bolesnika s poznatom tendencijom krvarenja ili u bolesnika koji primaju druge lijekove koji mogu produljiti vrijeme krvarenja.
English: Animal studies have shown excretion of bromfenac in the milk of rats following very high oral doses (see section 5.3).
Croatian: Ispitivanja na životinjama pokazala su izlučivanje bromfenaka u mlijeko štakorica nakon vrlo visokih oralnih doza (vidjeti dio 5.3).
English: However, following ocular administration plasma levels were not detectable (see section 5.2).
Croatian: Međutim, nakon okularne primjene, razine lijeka u plazmi nisu bile detektabilne (vidjeti dio 5.2).
English: pH: 8.1-8.5; osmolality: 270-330 mOsmol/kg
Croatian: Bistra žuta otopina. pH: 8,1-8,5; osmolalnost: 270-330 mOsmol/kg
English: Benzalkonium chloride has been reported to cause eye irritation, punctuate keratopathy and/or toxic ulcerative keratopathy.
Croatian: Prijavljeno je da benzalkonijev klorid uzrokuje iritaciju oka, točkastu keratopatiju i/ili toksičnu ulceroznu keratopatiju.
English: - if you have bleeding problems (e.g. haemophilia) or have had them in the past, or you are taking other medicines which may prolong bleeding time (e.g. warfarin, clopidogrel, acetylsalicylic acid).
Croatian: - ako imate ili ste imali probleme s krvarenjem (npr. hemofilija), ili uzimate druge lijekove koji mogu produljiti vrijeme krvarenja (npr. varfarin, klopidrogel, acetilsalicilatna kiselina).
English: Your vision may be blurred for a short time after using this eye drops.
Croatian: Prolazno zamućenje vida može uslijediti kratko vrijeme nakon primjene ovih kapi za oko.
English: EU/1/11/692/001
Croatian: BROJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/11/692/001
English: The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP.
Croatian: Nositelj odobrenja obavljat će dodatne farmakovigilancijske aktivnosti i intervencije, detaljno objašnjene u dogovorenom Planu upravljanja rizikom, a koji je opisan u Modulu 1.8.2 Odobrenja za stavljanje lijeka u promet, te svim sljedećim dogovorenim nadopunama Plana.
English: Ocular infection An acute ocular infection may be masked by the topical use of anti-inflammatory medicinal products.
Croatian: Očna infekcija Akutne očne infekcije mogu biti prikrivene zbog topikalne primjene protuupalnih lijekova.
English: Conjunctival hyperaemia Abnormal sensation in eye Ocular discomfort
Croatian: Konjuktivalna hiperemija Abnormalan osjet u oku Osjećaj neugode u oku
English: Bromfenac is a non-steroidal anti-inflammatory drug (NSAID) that has anti-inflammatory activity which is thought to be due to its ability to block prostaglandin synthesis by inhibiting primarily cyclooxygenase 2 (COX-2).
Croatian: Bromfenak je nesteroidni protuupalni lijek (NSAIL) s protuupalnim djelovanjem za koje se smatra da je posredovano blokiranjem sinteze prostaglandina inhibicijom primarno ciklooksigenaze 2 (COX-2).
English: If more than one topical ophtalmic medicinal product is being used, each one should be administered at least 5 minutes apart.
Croatian: Ako se koristi više od jednog topikalnog oftalmološkog lijeka, razmak između primjene dva lijeka mora biti najmanje 5 minuta.
English: There was significantly less anterior chamber cells and flare within the first 2 weeks post-surgery (85.1% of patients with flare score of ≤1) vs. placebo (52%).
Croatian: Primijećeno je znatno manje stanica i zamućenja u prednjoj očnoj sobici unutar prva 2 tjedna nakon kirurškog zahvata (85,1% bolesnika s rezultatom zamućenja ≤ 1) u odnosu na placebo (52%).
English: - Benzalkonium chloride is a preservative which may cause eye irritation or eye surface problems.
Croatian: - Benzalkonijev klorid je konzervans koji može izazvati iritaciju oka ili probleme na površini oka.
English: No biological relevant melanin binding was observed in vitro.
Croatian: In vitro nije zabilježeno biološki relevantno vezivanje melanina.
English: Write the date of opening on the carton label in the space provided.
Croatian: Zabilježite datum otvaranja bočice na predviđeno mjesto na kutiji.
English: Start using the drops the next day after your cataract surgery.
Croatian: Započnite s primjenom kapi sljedeći dan nakon operacije katarakte.
English: Sodium sulphite, anhydrous (E221) Tyloxapol
Croatian: Natrijev sulfit, bezvodni (E221) Tiloksapol
English: Studies in rabbits using radio-labelled bromfenac have demonstrated that highest concentrations after topical administration are observed in the cornea followed by the conjunctiva and the aqueous humour.
Croatian: Ispitivanja u kunića koja su koristila radioaktivno označeni bromfenak, pokazala su da su najviše koncentracije nakon topikalne primjene zabilježene u rožnici, zatim u konjuktivi i očnoj vodici.
English: Animal studies have shown excretion of bromfenac in breast milk when applied orally at doses of 2.35 mg/kg which is 2350 times the recommended ophthalmic dose.
Croatian: Ispitivanja na životinjama pokazala su da se bromfenak izlučuje u majčino mlijeko kada je primijenjen peroralno u dozama od 2,35 mg/kg, što je 2350 puta više od preporučene oftamološke doze.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS BOTTLE LABEL
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE NALJEPNICA NA BOČICI
English: - Bring the bottle tip close to the eye. - Do not touch your eye or eyelid, surrounding areas or other surfaces with the dropper.
Croatian: - Ne dodirujte oči ili očni kapak, okolna područja ili druge površine s kapaljkom.
English: Foreign body sensation in the eye, redness and inflammation of the eye, damage and inflammation of the surface of the eye, eye discharge, itching, irritation or pain of the eye, swelling or bleeding of the eyelid, impaired vision due to inflammation, floaters or moving spots before the eyes or diminishing vision that can indicate bleeding or damage of the back of the eye (retina), ocular discomfort, sensitivity to light, reduced or blurred vision, swelling of the face, cough, nosebleeding or runny nose.
Croatian: Manje česte nuspojave (mogu se javiti u manje od 1 na 100 osoba) Osjećaj stranog tijela u oku, crvenilo i upala oka, oštećenje i upala površine oka, iscjedak iz oka, svrbež, nadraženost ili bol u oku, oticanje ili krvarenje očnog kapka, oslabljen vid zbog upale, lebdeće mutnine ili leteće mušice pred očima ili pogoršanje vida koje može ukazivati na krvarenje ili oštećenje stražnjeg dijela oka (mrežnica), osjećaj neugode u oku, osjetljivost na svjetlo, umanjen ili zamagljen vid, oticanje lica, kašalj, curenje ili krvarenje iz nosa.
English: In general, contact lens wear is not recommended during the postoperative period following cataract surgery.
Croatian: Općenito, nošenje kontaktnih leća ne preporučuje se tijekom postoperativnog razdoblja nakon operacije katarakte.
English: If blurred vision occurs at instillation patients should be advised to refrain from driving or using machines until vision is clear.
Croatian: Ako dođe do zamagljenja vida nakon ukapavanja, bolesnicima treba savjetovati da se suzdrže od vožnje ili rada sa strojevima sve dok vid ne postane bistar.
English: Photophobia
Croatian: Fotofobija
English: The most common or most important reactions in the pooled studies were abnormal sensation in eye (0.5%), corneal erosion (mild or moderate) (0.4%), eye pruritus (0.4%), eye pain (0.3%) and eye redness (0.3%).
Croatian: Najčešće ili najvažnije nuspojave u udruženim ispitivanjima bile su abnormalan osjet u oku (0,5%), erozija rožnice (blaga ili umjerena) (0,4%), svrbež oka (0,4%), bol u oku (0,3%) i crvenilo oka (0,3%).
English: Patients with evidence of corneal epithelial breakdown should be instructed to immediately discontinue use of Yellox and should be monitored closely for corneal health (see section 4.4).
Croatian: Bolesnike s dokazanim oštećenjem epitela rožnice treba uputiti da odmah prekinu primjenu Yelloxa, a cijeljenje rožnice treba pažljivo pratiti (vidjeti dio 4.4).
English: In susceptible patients, continued use of topical NSAIDs, including bromfenac may result in epithelial breakdown, corneal thinning, corneal erosion, corneal ulceration or corneal perforation.
Croatian: U osjetljivih bolesnika, kontinuirana primjena topikalnih NSAIL, uključujući bromfenak, može dovesti do oštećenja epitela, stanjenja rožnice, erozije rožnice, ulceracije rožnice ili perforacije rožnice.
English: These comprised 3 (0.3%) patients with mild corneal erosion, 2 (0.2%) patients with eyelid oedema and 1 (0.1%) patient each with abnormal sensation in eye, corneal oedema, or eye pruritus.
Croatian: Oni su se sastojali od 3 (0,3%) bolesnika s blagom erozijom rožnice, 2 (0,2%) bolesnika s edemom kapka i 1 (0,1%) bolesnika s abnormalnim osjetom u oku, edemom rožnice ili svrbežom oka.
English: Yellox can be used during breast-feeding.
Croatian: Yellox se može koristiti tijekom dojenja.
English: Postmarketing experience with topical NSAIDs suggests that patients with complicated ocular surgeries, corneal denervation, corneal epithelial defects, diabetes mellitus and ocular surface diseases e.g. dry eye syndrome, rheumatoid arthritis or repeat ocular surgeries within a short period of time may be at increased risk for corneal adverse reactions which may become sight threatening.
Croatian: Postmarketinško iskustvo s topikalnim NSAIL pokazuje da bolesnici sa složenim kirurškim zahvatima na očima, denervacijom rožnice, defektom epitela rožnice, šećernom bolesti i bolestima površine oka, npr. sindromom suhog oka, reumatoidnim artritisom ili ponovljenim kirurškim zahvatima na očima u kratkom vremenu mogu biti pod povećanim rizikom od nuspojava na rožnici koje mogu ugroziti vid.
English: If you forget to use Yellox
Croatian: Ako ste zaboravili primijeniti Yellox